topic

  • Phosphorus binders: The new and the old, and how to choose
    Phosphorus binders: The new and the old, and how to choose
    Arjun Sekar, MD, Taranpreet Kaur, MD, Joseph V. Nally, MD, Hernan Rincon-Choles, MD, Stacey Jolly, MD, MAS, FACP and Georges N. Nakhoul, MD
    Cleveland Clinic Journal of Medicine August 2018, 85 (8) 629-638; DOI: https://doi.org/10.3949/ccjm.85a.17054

    The pathophysiology and control of hyperphosphatemia in kidney disease, focusing on phosphorus binders.

  • Phosphorus in kidney disease: Culprit or bystander?
    Malvinder S. Parmar, MB, MS, FRCPC, FASN
    Cleveland Clinic Journal of Medicine August 2018, 85 (8) 639-642; DOI: https://doi.org/10.3949/ccjm.85a.18013

    As kidney function declines, phosphorus accumulates, but the process is complex.

  • How well do we understand calcium and vitamin D?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 505-506; DOI: https://doi.org/10.3949/ccjm.85b.07018

    I do not believe we truly understand the ideal amount of dietary and supplemental calcium or vitamin D for a given patient.

  • Wolff-Parkinson-White pattern unmasked by severe musculoskeletal pain
    Rishi Raj, MD, Leon O’Neill, MD and Nasreen Shaikh, MD
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 507-509; DOI: https://doi.org/10.3949/ccjm.85a.17131

    WPW pattern can be asymptomatic, whereas the syndrome is characterized by symptomatic arrhythmias.

  • Osmotic demyelination syndrome due to hyperosmolar hyperglycemia
    Takanobu Hirosawa, MD and Taro Shimizu, MD, MPH, MBA
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 511-513; DOI: https://doi.org/10.3949/ccjm.85a.17020

    Rapid correction of chronic hyponatremia can trigger this rare but life-threatening disorder.

  • What inpatient treatments do we have for acute intractable migraine?
    Ashhar S. Ali, DO and Mark Stillman, MD
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 514-516; DOI: https://doi.org/10.3949/ccjm.85a.17049

    Options: volume repletion, antiemetics, antiepileptics, NSAIDs, corticosteroids, and magnesium sulfate. Avoid opioids.

  • When does S aureus bacteremia require transesophageal echocardiography?
    Aibek E. Mirrakhimov, MD, Michael E. Jesinger, MD, Taha Ayach, MD and Adam Gray, MD
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 517-520; DOI: https://doi.org/10.3949/ccjm.85a.16095

    TTE is a good starting point, but TEE is indicated in patients with a high pretest probability of endocarditis.

  • S aureus bacteremia: TEE and infectious disease consultation
    Susan J. Rehm, MD, FIDSA, FACP
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 521-522; DOI: https://doi.org/10.3949/ccjm.85a.18061

    Staphylococcus aureus bacteremia demands further evaluation, as up to 25% of people who have it may have endocarditis.

  • What should I address at follow-up of patients who survive critical illness?
    Dmitriy M. Golovyan, MD, Sikandar H. Khan, DO, Sophia Wang, MD and Babar A. Khan, MBBS
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 523-526; DOI: https://doi.org/10.3949/ccjm.85a.17104

    Cognitive decline, psychiatric disturbances, and physical weakness can persist 1 year or longer.

  • Critical care medicine: An ongoing journey
    Steven R. Insler, DO
    Cleveland Clinic Journal of Medicine July 2018, 85 (7) 527-528; DOI: https://doi.org/10.3949/ccjm.85a.18015

    Although 70% of ICU patients survive hospitalization, the mortality rate 1 year after discharge may exceed 50%.

Pages